Volume 25, Number 10—October 2019
CME ACTIVITY - Synopsis
Edwardsiella tarda Bacteremia, Okayama, Japan, 2005–2016
Table 1
Characteristic | Total, N = 26 | Survivors, n = 23 | Patients who died within 30 d after bacteremia onset, n = 3 | p value |
---|---|---|---|---|
Median age, y (IQR) [range] |
75 (63–85) [45–101] |
75 (64–85) [45–101] |
63 (30–87) [60–87] |
0.55 |
Sex, no. patients | ||||
M | 13 | 11 | 2 | 1.00 |
F |
13 |
12 |
1 |
|
Underlying disease, no. patients | ||||
Solid tumor | 12 | 10 | 2 | 0.58 |
Cardiovascular disease | 4 | 4 | 0 | 1.00 |
Diabetes mellitus | 3 | 3 | 0 | 1.00 |
Gallstone | 3 | 3 | 0 | 1.00 |
Chronic liver disease | 2 | 1 | 1 | 0.22 |
Cerebrovascular disease | 2 | 2 | 0 | 1.00 |
Hematologic malignancy | 1 | 1 | 0 | 1.00 |
Chronic kidney disease | 0 | 0 | 0 | NE |
Ulcerative colitis | 0 | 0 | 0 | NE |
Crohn disease | 0 | 0 | 0 | NE |
None | 4 | 2 | 2 | 0.052 |
Other |
0 |
0 |
0 |
NE |
Behavioral/dietary risk factors, no. patients | ||||
Alcoholism | 4 | 2 | 2 | 0.052 |
Exposure to raw food | 3 | 3 | 0 | 1.00 |
Exposure to fresh or marine water, animal feces |
1 |
1 |
0 |
1.00 |
Clinical diagnosis, no. patients | ||||
Cholangitis | 9 | 9 | 0 | 0.53 |
Liver abscess | 6 | 6 | 0 | 1.00 |
Enterocolitis | 4 | 4 | 0 | 1.00 |
Cholecystitis | 3 | 3 | 0 | 1.00 |
Spontaneous bacterial peritonitis | 1 | 0 | 1 | 0.115 |
Mycotic aneurysm | 1 | 1 | 0 | 1.00 |
Necrotizing fasciitis | 1 | 0 | 1 | 0.115 |
Empyema | 1 | 0 | 1 | 0.115 |
Febrile neutropenia | 1 | 1 | 0 | 1.00 |
Osteomyelitis | 1 | 1 | 0 | 1.00 |
Secondary peritonitis | 1 | 1 | 0 | 1.00 |
Focus unknown | 5 | 4 | 1 | 0.49 |
Receipt of chemotherapy for cancer |
4 |
4 |
0 |
1.00 |
Median duration of treatment for infection, d (IQR) [range]† | 12 (7–27) [1–77] | 13 (8–30) [1–77] | 5 (2–11) [2–11] | 0.084 |
*IQR, interquartile range; NE, not evaluated.
Page created: September 12, 2019
Page updated: September 12, 2019
Page reviewed: September 12, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.